Navigation Links
Patient-Specific Stem Cell Therapy to Halt or Reverse the Damage of Parkinson’s Disease Gets Support from National Stem Cell Foundation

Summit for Stem Cell has received a $250,000 grant from the National Stem Cell Foundation (NSCF) to support the development of a patient-specific stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is directed by Dr. Andrés Bratt-Leal in the lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, CA.

The aim of of the research is to use a patient’s own skin cells to create normal dopamine-producing neurons that can be returned to the patient without rejection. Dopamine, a chemical that sends messages to areas of the brain that control movement and coordination, is decreased in Parkinson’s when dopamine-producing neurons malfunction or die. This patient-specific therapy has the potential to halt or reverse the damage of Parkinson’s disease and other neurological disorders, including ALS.

According to Dr. Paula Grisanti, National Stem Cell Foundation Chairman, “As an organization, we are committed to partnering with strong organizations and building consortiums to get great research through the funding “valley of death” that is too often the fate of promising ideas. We are delighted to make this grant for patient-specific stem cell research that will advance treatment options for Parkinson’s and other neurodegenerative diseases.”

Jenifer Raub, Summit’s Board President, says, “The generous support provided by the National Stem Cell Foundation will advance this research at a critical point and move us closer to FDA-approved clinical trials. We are thrilled by this unique partnership with NSCF.”

About Summit for Stem Cell
Summit for Stem Cell is an all-volunteer organization working to fund research that will directly impact treatment options for the debilitating effects of Parkinson's disease. Summit is at the vanguard of a unique collaboration between patients, clinicians, scientists, volunteers, patient advocates and the community-at-large to move innovative research forward in cooperation with The Scripps Research Institute and Scripps Clinic. For more information visit:

About National Stem Cell Foundation
The National Stem Cell Foundation is a 501(c)3 non-profit organization funding stem cell and regenerative medicine research and clinical trials in four primary focus areas: Neurodegenerative Disease, Autoimmune Disease, Rare Childhood Disorders and Regenerative Repair. NSCF’s goal is to fund promising developments in the field of regenerative medicine, support research collaboration wherever possible and accelerate access to scientific breakthroughs for people in need. For more information visit:

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Hudsonville-Based Biomedical Startup, Imago Prints, Uses Patient-Specific Ultrasound Data to Produce One-of-a-Kind 3D Printed Renderings of Infants During Pregnancy
2. Seamless gene correction of beta-thalassemia mutations in patient-specific cells
3. University Of Colorado Cancer Center Tests Promising New Drug to Treat and Protect Against Radiotherapy-Associated Oral Mucositis
4. Transplanted brain cells in monkeys light up personalized therapy
5. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
6. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
7. Cellular Therapy and Cord Blood 2013 Market Report
8. Gene therapy may aid failing hearts
9. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
10. Arctic Animal, Warm Hearts: National Robotics Week Display Features Robot Therapy for Palliative and Dementia Care
11. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published in ... and fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched ... , After comparing the results from the fresh and frozen transfer cohorts, the ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/13/2017)... 2017 UBM,s Advanced Design and Manufacturing event ... emerging and evolving technology through its 3D Printing and ... alongside the expo portion of the event and feature ... focused on trending topics within 3D printing and smart ... event will take place June 13-15, 2017 at the Jacob ...
Breaking Biology News(10 mins):